Stevanato Group SpA
NYSE:STVN
Relative Value
The Relative Value of one STVN stock under the Base Case scenario is 32.95 USD. Compared to the current market price of 26.45 USD, Stevanato Group SpA is Undervalued by 20%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
STVN Competitors Multiples
Stevanato Group SpA Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
IT |
Stevanato Group SpA
NYSE:STVN
|
7B USD | 6 | 44.7 | 23.2 | 31.8 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.3B USD | 5.2 | 36.9 | 22.8 | 33.4 | ||
US |
Danaher Corp
NYSE:DHR
|
184B USD | 4.2 | 22.8 | 16.6 | 20.4 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.5B CHF | 5.6 | 57.3 | 19.7 | 28.9 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
40.5B USD | 2.7 | 29.9 | 16.3 | 25.2 | ||
US |
Agilent Technologies Inc
NYSE:A
|
40.9B USD | 6.1 | 33.1 | 26.4 | 31.8 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
54.9T KRW | 14.9 | 64 | 33.7 | 48.6 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.2 | 23.9 | 26.5 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.6B USD | 9.1 | 46.9 | 32.5 | 39.5 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
25.6B USD | 3.1 | 37.4 | 16.9 | 26 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.2B EUR | 7.1 | 75.4 | 32.4 | 53.2 |